Dr. Wagner has more than 20 years of experience developing sterile fill/finish services with an emphasis in new product and process development. She has worked with new business in firms ranging from virtual startups to global giants within the biotech, pharmaceutical and medical device industries.
Dr. Wagner started her career in sterile fill finish at a company acquired by Curia in 2010. She joined and accelerated the business and from a mere $250,000 per year to over 22 million per year when sold. Dr. Wagner led the success of the business through understanding and responding to the demanding needs of customers marshalling products through clinical trials to commercialization. Dr. Wagner closely monitors the coordination of the engineering, quality, manufacturing, and project management teams to meet the constantly changing customer requirements and critical deadlines. She has worked for larger and smaller CMO entities, and she applies her knowledge and energy to lead them to successful outcomes.
Dr. Wagner has participated in numerous workshops and conferences on the manufacturing of sterile drugs. She has also authored technical papers and written articles on outsourcing of drug and medical device products as well as assisted with technical presentations on fill/finish innovations, process scale up methodology and use of disposable technologies in aseptic manufacturing.
Dr. Wagner holds a Doctorate in Environmental Health and Toxicology from the State University of New York at Albany (SUNY), an MS in Analytical Chemistry, focus on separations from the University of Vermont and a Bachelor of Science from Northern Arizona University.
